Annals of Clinical and Translational Neurology (Jun 2024)

Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data

  • Marta Karas,
  • Julia Olsen,
  • Marcin Straczkiewicz,
  • Stephen A. Johnson,
  • Katherine M. Burke,
  • Satoshi Iwasaki,
  • Amir Lahav,
  • Zoe A. Scheier,
  • Alison P. Clark,
  • Amrita S. Iyer,
  • Emily Huang,
  • James D. Berry,
  • Jukka‐Pekka Onnela

DOI
https://doi.org/10.1002/acn3.52050
Journal volume & issue
Vol. 11, no. 6
pp. 1380 – 1392

Abstract

Read online

Abstract Background Passively collected smartphone sensor data provide an opportunity to study physical activity and mobility unobtrusively over long periods of time and may enable disease monitoring in people with amyotrophic lateral sclerosis (PALS). Methods We enrolled 63 PALS who used Beiwe mobile application that collected their smartphone accelerometer and GPS data and administered the self‐entry ALS Functional Rating Scale‐Revised (ALSFRS‐RSE) survey. We identified individual steps from accelerometer data and used the Activity Index to summarize activity at the minute level. Walking, Activity Index, and GPS outcomes were then aggregated into day‐level measures. We used linear mixed effect models (LMMs) to estimate baseline and monthly change for ALSFRS‐RSE scores (total score, subscores Q1–3, Q4–6, Q7–9, Q10–12) and smartphone sensor data measures, as well as the associations between them. Findings The analytic sample (N = 45) was 64.4% male with a mean age of 60.1 years. The mean observation period was 292.3 days. The ALSFRS‐RSE total score baseline mean was 35.8 and had a monthly rate of decline of −0.48 (p‐value <0.001). We observed statistically significant change over time and association with ALSFRS‐RSE total score for four smartphone sensor data‐derived measures: walking cadence from top 1 min and log‐transformed step count, step count from top 1 min, and Activity Index from top 1 min. Interpretation Smartphone sensors can unobtrusively track physical changes in PALS, potentially aiding disease monitoring and future research.